환자 제어 진통(PCA) 펌프 시장 : 유형별, 용도별, 최종 용도별 - 세계 예측(2024-2032년)

Patient-controlled analgesic pumps market is anticipated to register a CAGR of over 4.8% between 2024 and 2032, driven by increasing demand for effective pain management solutions in healthcare settings, particularly among patients undergoing surgical procedures. These pumps allow patients to self-administer pain medication within prescribed limits, providing personalized pain relief and enhancing patient satisfaction. Additionally, the rising prevalence of chronic conditions such as cancer and arthritis, which often require long-term pain management, drives the industry growth.

Manufacturers are continuously developing patient-controlled analgesic pumps with enhanced features such as programmable dosing options, wireless connectivity for remote monitoring, and ergonomic designs for ease of use. These technological advancements improve pump performance, safety, and user experience. Moreover, the integration of smart pump technology with electronic medical records systems streamlines documentation and enhances medication management practices. In March 2021, Smiths Medical issued the ECRI evaluation report for the CADD(R)-Solis v4, featuring wireless communication for the Patient-Controlled Analgesic (PCA) and epidural infusion pump.

Patient-controlled analgesic pumps industry is segmented based on type, application, end-use, and region.

Hematology segment will record a notable growth through 2032. The patients undergoing hematology-related procedures, such as bone marrow biopsies, hematopoietic stem cell transplants, or chemotherapy for hematological malignancies, often experience pain requiring effective pain management solutions. These pumps offer a personalized and controlled approach to pain relief, allowing patients to self-administer medication as needed within prescribed limits. This level of autonomy empowers patients to manage their pain effectively, leading to improved pain control, reduced opioid consumption, and enhanced overall patient satisfaction.

Ambulatory surgical centers segment is slated to generate notable revenues during 2024-2032, attributed to the increasing shift towards outpatient surgical procedures due to cost-effectiveness, convenience, and advancements in minimally invasive techniques. Additionally, the compact size and portability of patient-controlled analgesic pumps make them well-suited for use in ASCs, where space may be limited, and mobility is essential.

Asia Pacific patient-controlled analgesic pumps industry will record a notable growth through 2032, backed by the region's rapidly aging population and increasing prevalence of chronic diseases. There is a growing adoption of patient-centered care approaches and emphasis on improving patient outcomes. The advancements in healthcare infrastructure and rising healthcare expenditure in countries like China, Japan, and India are stimulating the regional industry expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & working
• 1.3 Data collection
• 1.4 Forecast calculations
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of chronic pain conditions
    • 3.2.1.2 Advancements in pump technologies
    • 3.2.1.3 Growing number of surgical procedures
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of PCA pumps
    • 3.2.2.2 Risk of infection and complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Porter's analysis
  • 3.5.1 Supplier power
  • 3.5.2 Buyer power
  • 3.5.3 Threat of new entrants
  • 3.5.4 Threat of substitutes
  • 3.5.5 Industry rivalry
• 3.6 PESTEL analysis
• 3.7 Future market trends
• 3.8 Technological landscape
• 3.9 Pricing analysis
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Electronic and wireless
• 5.3 Mechanical

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oncology
• 6.3 Diabetes
• 6.4 Hematology
• 6.5 Gastroenterology
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Ambulatory surgical centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Ace-medical
• 9.3 B. Braun Medical Inc.
• 9.4 Becton, Dickinson and Company
• 9.5 Changzhou Medical Bioengineering Co., Ltd.
• 9.6 Fresenius SE & Co. KGaA
• 9.7 Henan Tuoren Medical Device Co., Ltd.
• 9.8 ICU Medical, Inc.
• 9.9 Micrel Medical Devices SA
• 9.10 SCW MEDICATH LTD.